Live Program Date: Wednesday, August 18, 2021
Program Number: 21EL-664

Educational Track: Technical/Clinical
Topics: Antibody Identification, Blood Groups, Immunohematology, Patient Transfusion, Special Patients and Situations, Transfusion Safety
Intended Audience: Hospital Blood Banks, Hospitals, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Students (MD, MT, SBB), Technologists
Teaching Level: Intermediate

Faculty
(titles and affiliations at the time of the live program)
Director/Moderator: Laura Nelson MLS(ASCP)SBB^cm, Testing Services Supervisor II, LifeServe Blood Center, Des Moines, IA
Speaker: Sue Johnson, MSTM, MT(ASCP)SBB^CM, Director, Clinical Education, Versiti, Director, Transfusion Medicine Program, Marquette University, Milwaukee, WI

Program Description
Immune hemolytic anemia (IHA) is rarely drug-induced, therefore when it is caused by a drug-dependent antibody, laboratories and clinicians can struggle with identifying the issue. This boot camp will further the participant’s understanding of drug-induced immune hemolytic anemia (DIIHA), and how to identify a patient possibly experiencing this type of hemolytic anemia. DIIHA can mimic warm and cold autoantibodies so a discussion of the serologic findings and clinical information needed to differentiate them will be included. This program will also review different drugs known cause DIIHA and the importance of reviewing timing and dosage to further educate blood bankers/medical laboratory scientists and clinicians on what to look for in a patient medication history.

Learning Objectives
After participating in this educational activity, participants should be able to:

Describe the different categories of drug-induced immune hemolytic anemia (DIIHA).
List the most common drugs causing DIIHA.
Describe the serologic findings of DIIHA in the laboratory.
Distinguish drug-dependent antibodies from warm or cold autoantibodies.
Describe the current testing methodologies available for identifying drug-dependent antibodies causing DIIHA.

How to Claim Continuing Education Credit

Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.
Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to eLearning@aabb.org within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.

Laura Nelson MLS(ASCP)SBB

Testing Services Coordinator II, LifeServe Blood Center

Appearances